Jennifer Guo
Psychiatry · San Francisco, CANPI 1629463518
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,902 of the $18,483 with a category attached, or 91.4%. Janssen Scientific Affairs, LLC accounts for 92.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $8,980 and has fallen 94.4% since, to $507 in 2025. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $410.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$17K
- Johnson & Johnson$832
- Bausch Health US, LLC$139
- Otsuka America Pharmaceutical, Inc.$102
- AbbVie$92
- Takeda Pharmaceuticals U.S.A., Inc.$50
- plus $118 from 5 others
What the payments were for
- Consulting fees$16,90291%
- Speaking & faculty fees$6003%
- Food & beverage$9815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 15 | $17,151 |
| Johnson & Johnson | 4 | $832 |
| Bausch Health US, LLC | 8 | $139 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| AbbVie(2 entities) | 6 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Adlon Therapeutics L.p. | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Novartis | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$5,710
- INVEGA SUSTENNA$507
How this compares
$18,483 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 15 | $1,361 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in San Francisco
- John KooSan Francisco$3M
- Thomas LewisSan Francisco$135K
- Gustavo AlvaOrange$5.8M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.